Drug search by name
Aprepitant Capsules and Daclizumab Subcutaneous
Determining the interaction of Aprepitant Capsules and Daclizumab Subcutaneous and the possibility of their joint administration.
Check result:
Aprepitant Capsules <> Daclizumab Subcutaneous
Relevance: 27.11.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Aprepitant Capsules
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Daclizumab Subcutaneous
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Aprepitant Capsules-Dacogen
- Aprepitant Capsules-Dacomitinib
- Aprepitant Capsules-Dactinomycin
- Aprepitant Capsules-Dactinomycin Injection
- Aprepitant Capsules-Dactinomycin Intravenous
- Aprepitant Capsules-Daklinza
- Daclizumab Subcutaneous-Aprepitant Injection
- Daclizumab Subcutaneous-Aprepitant Intravenous
- Daclizumab Subcutaneous-Aprepitant Oral Suspension
- Daclizumab Subcutaneous-Aprepitant/Fosaprepitant Dimeglumine
- Daclizumab Subcutaneous-Apresazide
- Daclizumab Subcutaneous-Apresoline
Doktika World
Interaction with food and lifestyle
Disease interaction